As we welcome the New Year, we would like to extend our warmest wishes to the global ISAM community. The year ahead brings exciting opportunities to connect and exchange knowledge, including our ISAM Conference in Taipei this July and a series of planned webinars.

We encourage you to take part in these events, and we look forward to another productive year of scientific exchange and collaboration within ISAM.

With best wishes for a healthy, successful, and inspiring New Year,

What better way to start the new year than by making your plans for ISAM 2026?

The 26th International Society for Aerosols in Medicine (ISAM) Congress will take place July 13–16, 2026, in Taipei, Taiwan, and we are excited to announce that abstract submission and registration are now open.

After nearly three decades, ISAM returns to Asia, showcasing the latest advances in respiratory drug delivery, inhalation toxicology, and digital health. Bringing together experts from 15 countries, this Congress marks the first ISAM meeting held in Asia in over 30 years and proudly features strong representation from the Asian scientific community alongside international leaders. We warmly invite researchers, clinicians, industry leaders, and trainees from around the world to join us for a truly global congress in the heart of Taipei.

Submit an Abstract Register Now

Plenary Speakers You Won’t Want to Miss

ISAM 2026 will feature world-leading plenary speakers whose work spans aerosol science, inhaled drug delivery, and clinical translation:

• Hak-Kim Chan (University of Sydney) – International leader in aerosol drug delivery and inhaled medicines, with seminal contributions spanning formulation, modeling, lung imaging, and clinical translation.
  Recipient of the 2023 ISAM Career Award.
• Chantal Darquenne (UC San Diego) – Renowned expert in aerosol transport and deposition, lung ventilation, and respiratory physiology; former ISAM President (2019–2021).
  Recipient of the 2023 Thomas T. Mercer Award (AAAR & ISAM).
• Omar Usmani (Imperial College London; Royal Brompton Hospital) – International authority in inhaled drug delivery, small airways physiology, lung imaging, and digital health; former ISAM President (2023–2025).
  Recipient of the 2015 Thomas T. Mercer Award (AAAR & ISAM).

Scientific Program Highlights

ISAM 2026 will deliver a dynamic, interdisciplinary scientific program spanning fundamental aerosol science, translational engineering, clinical practice, and regulatory perspectives. Sessions are designed to foster cross-sector dialogue and highlight both established and emerging areas shaping the future of aerosol medicine. The scientific program comprises eight thematic sessions spanning six networking group topics, three flash talk sessions, and a Best Oral Presentation session highlighting exceptional research.

Abstracts are invited for poster presentations and flash talks, providing opportunities to showcase cutting-edge research, highlight emerging ideas, and elevate early-career investigators and trainees. Chaired poster sessions will serve as a central hub for scientific exchange and networking throughout the congress, offering participants a valuable opportunity for in-depth, face-to-face scientific exchange with authors in a collegial and collaborative environment.

Program Overview Travel to Taipei

Sponsors & Partners

ISAM 2026 would not be possible without the generous support of our sponsors and partners. We extend our sincere thanks to our past and current sponsors for their continued commitment to advancing aerosol medicine.

We warmly welcome new sponsors and exhibitors to join us in Taipei and engage with a global community spanning academia, clinical practice, and industry innovation. Sponsorship packages include exhibition space, branding opportunities, scientific session support. In addition, a newly introduced session, “Partner Showcase – Innovation in Aerosol Medicine,” will provide an interactive platform for industry partners to present cutting-edge technologies and translational innovations. Customized options are also available.

Sponsor & Exhibitor Information

Join Us in Taipei

The Congress will be held at the National Taiwan University Hospital (NTUH) International Convention Center, located in the vibrant center of Taipei. This modern venue offers excellent facilities and convenient access to cultural sites, local cuisine, and public transportation.

For full details about the congress, including venue, schedule, and updates, please visit the ISAM 2026 Congress website.

ISAM 2026 Congress Information

We look forward to welcoming you to Taipei in July 2026 to exchange ideas, foster collaboration, and advance the field of aerosol medicine together.

The European Respiratory Society (ERS), the world’s largest respiratory medicine congress, was held in Amsterdam from 27 September to 1 October 2025. As the leading global membership organization in aerosol science and inhalation medicine, the International Society of Aerosols in Medicine (ISAM) has regularly engaged with ERS for over a decade to represent and promote our discipline.

It was therefore rewarding to see these efforts reflected across the five-day programme this year, with diverse inhalation-related disciplines featured in posters, oral sessions, and symposia covering:

• Inhaled drug formulations
• Environmental bioaerosols
• Lung in silico modeling and respiratory physiology to assess drug delivery
• New propellants for metered dose inhalers (MDIs)
• Intranasal vaccines and digital inhalers
• Emerging opportunities for inhaled drug delivery to treat respiratory disease

Sessions were highly engaging, bringing together clinicians, respiratory healthcare professionals, critical care specialists, aerosol scientists, inhalation toxicologists and engineers, pharmaceutical scientists, and regulatory and product development experts. A highlight was the long-standing Tuesday lunchtime Inhalation Symposium, now in its 10th year, which ISAM helped establish over a decade ago and which remains a regular feature of the ERS scientific programme.

ISAM was again well represented this year. In the enclosed photo, ISAM Board Members can be seen reconnecting at the congress:

• Monbi Chakma (Young Investigator Board Member), who presented her work on “Dry powder inhaler resistance: understanding patient preference and confidence using the In-Check DIAL.”
• Omar Usmani (Past President), who delivered a presentation on “Choosing the right inhaler and implementing improved inhaler technique in the clinic.”
• Sabine Häussermann (President-elect), who engaged with new scientific insights being presented at the congress to help inform evidence development initiatives in her role as newly appointed Chief Scientific Officer of VisionHealth.

ISAM maintains a joint membership arrangement with ERS. When joining ISAM, members may add ERS membership at a discounted rate of 30 Euros per year (approximately 35 USD), compared with the standard ERS membership fee of 200 Euros per year. The extensive benefits of ERS membership for scientists, clinicians, regulatory professionals, and industry experts are outlined on the ERS membership page.

Looking ahead, the ERS Congress 2026 will take place in Barcelona, Spain, from 5–9 September 2026. Members of the ISAM Board will again be in attendance and hope to organize an ISAM member meet-up. Further details can be found on the ERS Congress website.

Time to Renew Your ISAM Membership

A new year brings new opportunities to connect, contribute, and stay engaged with the global aerosol medicine community. ISAM membership renewals are now open, and while reminders will be sent, why wait?

We encourage all members to take a moment to review and renew their membership, update their profile, and engage with fellow members through ISAM’s discussion boards and networking forums.

View or Renew Your Membership

Benefits of Regular ISAM Membership

• Online access to the Journal of Aerosol Medicine and Pulmonary Drug Delivery (JAMPDD), featuring the latest research and reviews in aerosol science and inhalation medicine.
• Access to the ISAM Textbook of Aerosol Medicine, authored by leading experts and covering fundamental and clinical aspects of aerosol therapy.
• Exclusive member resources, including networking forums, educational materials, registered member listings, and direct journal access.
• Engagement opportunities for Young Investigators, including student forums, special networking events, and programming at ISAM congresses.
• Discounted registration fees for ISAM congresses, workshops, and events.

Please note that membership dues are assessed annually and should be paid by the end of January.

Membership for Students and Trainees

ISAM is deeply committed to supporting the next generation of aerosol scientists, clinicians, and engineers. Discounted student memberships provide an affordable entry point into the Society and open the door to meaningful engagement and professional development.

• Participation in ISAM networking and scientific interest groups, including leadership roles
• Eligibility for student and trainee awards, including travel awards, best oral and poster presentation awards
• Access to ISAM webinars, educational content, and Society communications
• Opportunities to connect directly with experts and leaders in aerosol medicine
• Reduced registration fees for ISAM congresses and events

Students and trainees are encouraged to get involved early, build their professional networks, and take full advantage of everything ISAM has to offer!

Join ISAM Today

Your continued engagement is essential to the strength of our Society. Thank you for being an active part of ISAM.

Finally, we are excited to promote ISAM’s official LinkedIn corporate page – a central platform for updates, insights, and connection within the global aerosol medicine community.

By following our page, you will stay informed about:

• Upcoming events and congresses, including the 26th International ISAM Congress in Taipei, Taiwan, as well as webinars and special initiatives.
• Society news and highlights from ISAM’s international networking and engagement activities.
• Mission-driven content such as research insights, educational resources, and information on member benefits, including our official journal and collaborative opportunities.

As part of ISAM’s ongoing digital transformation, we are moving to a single, unified presence on LinkedIn. Going forward, there will be no standalone LinkedIn pages for individual networking groups. All communication, updates, and community engagement will take place centrally through ISAM’s global LinkedIn page.

What we invite you to do:

1. Visit our new page: ISAM on LinkedIn
2. Follow us to receive ISAM updates directly in your LinkedIn feed.
3. Engage with our content through likes, comments, and shares to help strengthen our global network.

By joining us on our official LinkedIn page, you help amplify ISAM’s voice, foster meaningful connections, and support the advancement of aerosol science in medicine worldwide.

Thank you for being part of our mission—we look forward to connecting with you on LinkedIn.

Looking Ahead to an Exciting Year with ISAM

As we move into 2026, ISAM looks forward to a year filled with scientific exchange, global collaboration, and opportunities to connect across disciplines and regions. From upcoming webinars and society initiatives to our return to Asia for the ISAM 2026 Congress in Taipei, there is much to look forward to in the months ahead.

Thank you for being an engaged and valued member of the ISAM community. We look forward to sharing more updates with you soon and to another productive year advancing aerosol science and inhalation medicine together.

Invitation and Agenda to General Assembly of ISAM International Society for Aerosols in Medicine

Dear ISAM Member,

We would like to invite you to attend the ISAM General Assembly to be held on

Tuesday June 24th, 2025, from 13:45 am to 15:00 pm

during the 25th ISAM congress in College Park, Washington DC, US.

Please find attached the proposed agenda for the General Assembly.

• Link to the Agenda of the General Assembly: isam_ga_agenda_june_2025.pdf

With kind regards,

Philip Kuehl, PhD General Secretary, ISAM

pkuehl@lovelacebiomedical.org

Omar Usmani

President, ISAM

o.usmani@imperial.ac.uk

Dear ISAM Member,

This is a reminder for you, as a member, to cast your vote in the ISAM board election.

As per the ISAM Statutes, voting for the election of the new board for the 2025–2027 term must begin three months before the next General Assembly, which will be held at the ISAM Congress in Washington DC this coming June.

ISAM Office has sent you an email with a link to the web tool SurveyMonkey™. To vote, please use the web link provided via email to access the electronic ballot.

Please contact the ISAM Office if you have NOT RECEIVED this email. We will then provide you with the voting link. Use this Link to contact ISAM Office. 

You can view the list of proposed candidates here:

Candidates ISAM Board Elections 2025-2027

Biosketches of all nominated candidates are included in the ballot, listed alphabetically within each category.

Voting Instructions

Please vote for:

• One candidate for President-Elect
• One candidate for General Secretary
• One candidate for Treasurer
• Five candidates for regular board members

Important Notes

Your vote will be invalid if:

• You select more candidates than allowed.
• Your ISAM membership has not been renewed for 2025.

To ensure your vote is valid, please renew your membership by the end of the election period, no later than  24, 2025. If you have not yet renewed, you can do so here: Join ISAM.

You will be required to enter your name on the ballot for eligibility verification. Your name will appear on a separate webpage from the voting ballot. Only the Past President (Barbara Rothen-Rutishauser) will have access to this information, and names will be deleted once eligibility has been confirmed, before vote counting begins.

To cast your vote, select the candidate’s name by clicking the circle next to it. Follow the same process for each position. If you prefer to vote for a substitute candidate instead of those listed, click the circle next to ‘Substitution’ and enter the substitute’s name in the provided box.

Please complete your ballot before April 24, 2025. We encourage you to vote as soon as possible to avoid missing the deadline. Votes will only be tallied after the deadline has passed.

The election results will be announced at the General Assembly on June 24, 2025, during the ISAM Congress in Washington DC, USA. An agenda for the General Assembly will be sent to you soon.

I look forward to seeing you all at the ISAM Congress in Washington DC!

With kind regards,

Philip Kuehl, PhD

General Secretary, ISAM

Dear ISAM Member,

As per the ISAM Statutes, voting for the election of the new board for the 2025–2027 term must begin three months before the next General Assembly, which will be held at the ISAM Congress in Washington DC this coming June.

The election will be conducted online by the ISAM Office using the web tool SurveyMonkey™. To vote, please use the web link provided via email to access the electronic ballot.

You can view the list of proposed candidates here:

Candidates ISAM Board Elections 2025-2027

Biosketches of all nominated candidates are included in the ballot, listed alphabetically within each category.

Voting Instructions

Please vote for:

• One candidate for President-Elect
• One candidate for General Secretary
• One candidate for Treasurer
• Five candidates for regular board members

Important Notes

Your vote will be invalid if:

• You select more candidates than allowed.
• Your ISAM membership has not been renewed for 2025.

To ensure your vote is valid, please renew your membership by the end of the election period, no later than  24, 2025. If you have not yet renewed, you can do so here: Join ISAM.

You will be required to enter your name on the ballot for eligibility verification. Your name will appear on a separate webpage from the voting ballot. Only the Past President (Barbara Rothen-Rutishauser) will have access to this information, and names will be deleted once eligibility has been confirmed, before vote counting begins.

To cast your vote, select the candidate’s name by clicking the circle next to it. Follow the same process for each position. If you prefer to vote for a substitute candidate instead of those listed, click the circle next to ‘Substitution’ and enter the substitute’s name in the provided box.

Please complete your ballot before April 24, 2025. We encourage you to vote as soon as possible to avoid missing the deadline. Votes will only be tallied after the deadline has passed.

The election results will be announced at the General Assembly on June 24, 2025, during the ISAM Congress in Washington DC, USA. An agenda for the General Assembly will be sent to you soon.

I look forward to seeing you all at the ISAM Congress in Washington DC!

With kind regards,

Philip Kuehl, PhD

General Secretary, ISAM

This group focuses on the Formulation of Orally Inhaled and Nasal Drug Products (OINDP), covering a wide range of topics, including:

• Dry powders, liquids for nebulizers, metered-dose inhalers, and nasal sprays
• Formulation strategies and development challenges
• Excipient selection, stability, and aerosol performance
• Device compatibility and regulatory considerations

Whether you're a researcher, formulation scientist, or regulatory expert, this is your opportunity to connect with leading professionals, exchange insights, and help shape the future of effective, patient-friendly OINDP therapies.

How to Join

1. Log in to the membership area of the ISAM website
2. Select 'Groups' from the menu
3. Scroll down and click 'Join Group' under Formulation of OINDP

Be part of the conversation and help drive innovation in aerosol medicine! 

How to Renew Your Membership

1. Sign-in to the Membership Area as described below.

If you have forgotten your password, you can connect to us or reset your password by clicking 'sign in' and 'click here to reset your password' and then reset the password. Please also connect to us if you do not remember your login details. CONTACT US

2. Select 'Renew Membership Now' from the 'Welcome' menu

3. Select your prefered Membership (e.g. Joint ISAM-ERS Membership)

4. Complete required information

Please complete required information and contact details, accept terms and check out 'PayPal'. Use this option also in the case if you dont have a PayPal account and pay via Credit Card.

You are then forwarded to PayPal, where you can pay with directly with PayPal or by selection of Credit Card for payment in the PayPal window.

In case you want to pay with credit card please perform following steps: (a) click on 'check out with paypal', (b) 'Continue without a paypal account', (c) use 'guest email' and pay with your credit card details without using the paypal account.

Following information is for all ISAM members having signed up for the Joint ISAM-ERS membership. Alongside an opportunity for members to take on official and essential roles within the European Respiratory Society (ERS) structure, Joint ISAM-ERS members also have an opportunity to have their say about the future leaders of the Society through open voting.

Link to ERS society

Senior Elections

Voting is now open for the following positions within the ERS Leadership:

• Vice President 2024/2025 (President 2026/2027)
• Secretary General Elect
• Treasurer Elect
• Science Council Chair Elect

The voting will end on 28 July, 2024.

Please, cast your votes on MyERS.

Many ISAM members attended and contributed to the Drug Delivery to the Lungs Conference (DDL) in Edinburgh, Scotland.  Greetings from attending ISAM Board members.

Press Release for download (German)

Press Release for download (English)

Experts on inhalable medicines meet on the campus of Saarland University

The ISAM Conference in Saarbrücken

Pharmacists, physicians, biologists, physicists and engineers from all over the world will meet in Saarbrücken from 26 to 30 August: The 24th Congress of the International Society for Aerosol Medicine (ISAM) will bring together more than 250 scientists from 20 countries on the campus of Saarland University. For five days, they will exchange ideas on respiratory diseases - for example caused by the corona virus -, inhaled medicines and health risks caused by environmental aerosols.

"The aim of the conference is to exchange information on the current state of the art in aerosol medicine. The programme includes more than 50 lectures - on medical, pharmaceutical, physical and technical aspects," explains Claus-Michael Lehr. The Professor of Biopharmacy and Pharmaceutical Technology at Saarland University and Head of the Department Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is organising this year's congress together with Marc Schneider, Professor of Biopharmacy and Pharmaceutical Technology, and Robert Bals, Director of the Clinic for Pneumology, Allergology, Respiratory and Environmental Medicine at University Clinic in Homburg.

After several years of the Corona pandemic and in the spirit of the research at HIPS, infectious diseases, and namely the topic of "viral infections and COVID", are a focus of the Saarbrücken congress, where virologist Christian Drosten is also expected to attend. Another central topic is cell culture models as an alternative to animal experiments, especially in connection with the transport of drugs across biological barriers (in this case the lungs) and their administration as inhalable aerosols. Claus-Michael Lehr illustrates: "Our inner lung surface is as large as a tennis court but only one micrometre (i.e. one thousandth of a millimetre) thick." This "air-blood barrier", which is supposed to retain pathogens or toxic substances from the environment but allow inhaled medicines to pass through, is one of the research foci in Saarbrücken.

In addition to pharmacists, respiratory and intensive care physicians, aerosol scientists, inhalation toxicologists and medical technicians will participate in the congress. The experts come both from academic research and - as experts for product development and approval - from industry. Within the framework of an industrial exhibition, 21 companies will inform about their current technologies and products. A large part of the participants are young scientists, i.e. doctoral students and postdocs.

The ISAM – International Society for Aerosols in Medicine was founded in 1973; its conferences, which take place every two years at different locations around the world, are among the world's largest conferences on respiratory health and inhaled drug delivery.

The Saarbrücker ISAM Conference will take place from 26 to 30 August. On the first day of the event, 26 August, workshops will be offered to teach the basics of aerosol medicine (including inhalation medicine and toxicology, aerosol modelling, inhalers, cell culture models). The official conference opening will take place on the same day from 5 pm. The industrial exhibition will be open on all conference days.

Link to the conference: https://isam.org/page/2023-ISAM-Congress

Venue: Saarland University, Campus Saarbrücken

Questions will be answered by:

Prof Dr Claus-Michael Lehr
Head of the department Drug Delivery across Biological Barriers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and University Professor for Biopharmacy and Pharmaceutical Technology (UdS)
Tel.: +49 (0)681 98806-1000
E-mail: claus-michael.lehr@helmholtz-hips.de

Prof Dr Marc Schneider
Saarland University, Professor for Biopharmacy and Pharmaceutical Technology
Tel.: +49 (0)681 302-2438
E-mail: Marc.Schneider@uni-saarland.de

Prof Dr Dr Robert Bals
Director of the Clinic for Internal Medicine V - Pneumology, Allergology, Respiratory and Environmental Medicine at the University Clinic in Homburg
Tel.: +49 (0)6841 16-15051
E-mail: robert.bals@uks.eu

Several ISAM Members have received emails linking to fraudulent websites, companies and individuals or link to offer ISAM Congress registrations, hotel bookings, attendee lists and other services.

ISAM does not accept any responsibility for bookings made via unofficial websites/agencies or any money lost as a result. This website is the official and only ISAM Congress website.

If you receive a suspicious emails, verify the sender of the email and please contact ISAM via our contact form (Contact-us) before you proceed with any payments or money transfers.

Your ISAM Office

Aerosol School goes virtual for 2023

After pausing for several years due to the COVID-19 pandemic, the 2023 edition of Aerosol School will take place virtually. Students will have access to more than 200 hours of lectures from well-known experts on topics ranging from the basics of aerosol delivery devices to hot topics such as the delivery of macrophages and monoclonal antibodies via inhalation. Registration is now open.

• Registration Link: http://aerosolschool.com/registration.php

Aerosol School is co-sponsored by the McMaster University Firestone Institute for Respiratory Health, St. Joseph’s Healthcare, and the International Society for Aerosols in Medicine (ISAM). A one-year membership in ISAM is included in the registration fee. To date, approximately 240 students have completed the program, which previously took place annually as in-person program at McMaster, starting in 2009.

McMaster professor Myrna Dolovich, Aerosol School’s founder and director, explains that the 2023 virtual version will be asynchronous, with registrants receiving links to view each of the 20 lectures on a private YouTube channel. The videos will be available for students to view over a 4-6 month period, and faculty members will be available to answer questions via email.

Returning faculty for the 2023 Aerosol School include OINDP consultant Jolyon Mitchell, Aerogen Pharma Chief Scientific Officer Jim Fink, Recipharm Director of Inhalation Science and Product Development, and McMaster professors Mark Inman and Helen Neighbour. New faculty members this year include Prof. Melissa Gomez, who is speaking about inhalable mAb formulations and Prof. Zeinab Hosseinidoust, who is presenting a talk on “Bacteriophages as surrogates for infectious viral aerosols.” Another new faculty member, Lynn Jordan of Proveris Scientific, will demonstrate the use of Proveris’ SprayView spray characterization system and Vereo automated actuators.

“It’s been a very beneficial program for those with a variety of pharma experiences,” Dolovich says, “for those who are just starting in the field and those who have been involved in various aspects of development, from performing bench measurements to manufacturing product to assessing clinical effects and to participating in the regulatory approval process. The faculty all have broad experience in the many aspects of the development of systems for providing therapeutic aerosols. Aerosol School provides the opportunity to connect with people who have a lot of experience in the medical aerosol field.”

The full virtual program is available to view here, and Dolovich suggests that bonus lectures may be added in the next few months.

Dear ISAM Member,

We would like to invite you to attend the ISAM General Assembly to be held on Tuesday August 29th, 2023, from 11:00 am to 12:00 pm during the 24th ISAM congress in Saarbrücken, Germany. 

Please find attached the agenda for the General Assembly, as well as a document highlighting in red some editorial changes and two specific changes to the ISAM statutes (§6.1 and §7.4) that are proposed by the Board.

• Link to the Agenda of the General Assembly: isam_ga_agenda_august2023.pdf
  
• Link to the Proposed Statutes: statutes_english_v_5_final.pdf (with redline)

The proposed changes to the contents of the statutes are related to agenda point 12 in the agenda where we will present some ideas about future conference organizations. The changes will be presented during the General Assembly and require a two-thirds majority vote of ISAM members attending the General Assembly in order to be enacted.   

With kind regards,

Philip Kuehl,
PhD General Secretary, ISAM
pkuehl@lovelacebiomedical.org

Barbara Rothen-Rutishauser
President, ISAM
barbara.rothen@unifr.ch

According to ISAM Statutes, voting for the election of the new board for the period 2023 - 2025 must begin at least 3 months before the next General Assembly, to be held at the ISAM Congress in Saarbrücken this coming August.

The election will be conducted online by the ISAM Office, using the web tool SurveyMonkey™. To vote, please use the web link provided by email to you to access the electronic ballot.

See the proposed candidate list here:

isam_board_candidates_2023.pdf

Biosketches of all the candidates that have been nominated are presented in the ballot (in alphabetical order in the different categories).

Please vote for

• one candidate for President-Elect
• one candidate for General Secretary
• one candidate for Treasurer
• five candidates for regular board members.

Your vote will be invalid:

• if you vote for more candidates than allowed.
• if your membership has not been renewed for 2023.

Membership must be renewed by the end of the election period, June 29, 2023, at the latest, in order for your vote to be valid. If you have not yet renewed your ISAM membership, you can do so here: https://isam.org/page/JoinUs

You will need to enter your name on the ballot, so that your eligibility to vote can be checked. Your name will appear on a separate web page to the voting ballot. Only the Past President (Chantal Darquenne) will have access to this information, and will delete the names once voting eligibility has been confirmed, before counting the votes.

Select the name of the person you want to vote for by clicking the circle next to their name. Follow the same procedure for all the names you wish to vote for. If you wish to vote for a substitute instead of those listed, click the circle next to ‘Substitution’ and type the substitute’s name in the box provided.

Please complete your ballot before June 29, 2023. Vote as soon as possible so as not to miss the deadline. The votes will only be tallied after the deadline has passed.

The results of the election will be presented at the General Assembly August 29., 2023 during the ISAM conference in Saarbrücken, Germany. An agenda for the General Assembly will be sent to you shortly.

I look forward to seeing you all in Saarbrücken!

With kind regards,

Philip Kuehl,

PhD General Secretary, ISAM

pkuehl@lovelacebiomedical.org

Thomas O'Riordan

Earlier this year, the founder and Editor-in-Chief Dr. Gerald Smaldone retired after 35 years with the Journal of Aerosol Medicine and Pulmonary Drug Delivery. He had a consistent vision for the journal and commitment to the field of aerosol medicine. I am honored to be his successor and have the opportunity to build on the strong foundation that he has established. In partnership with the publisher Mary Ann Liebert, the International Society for Aerosols in Medicine (ISAM), the dedicated community of reviewers who continue to share expertise and countless hours enhancing the quality of the submitted articles, and most importantly the committed scientists whose work has been published in the journal, I would like to say, “Thank you! I am delighted to continue this legacy.”

I will continue the peer review process established by Dr. Smaldone, which was notable for its transparency with most reviewers electing to have their names published at the end of the article they reviewed, and for the detailed and constructive feedback provided to authors to enhance the scientific rigor applied to methodology and presentation. In partnership with ISAM, it can be argued the journal has had a major influence in establishing the standard by which clinical drug deposition data are quantified and presented in the broader medical literature. The journal provides a cross-disciplinary forum for experts in devices, formulation, clinical science, toxicology, modeling, public policy, and the regulation of drug development to encourage communication and scientific engagement.

Carsten Ehrhardt from the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, has accepted the position of associate editor. Carsten takes over Tim Corcoran and we are very grateful for Tim's service as associate editor. I am delighted that Tim will serve on the editorial board and I am glad to add another eight distinguished new members to the board, with diverse backgrounds and experience in clinical and nonclinical research.

As the journal moves into its next stage, we encourage all those who have contributed articles to the journal in the past to continue to submit their new research work to the journal.

The journal has published articles on a diverse range of topics related to aerosols in medicine. My vision for the next phase in the journal's development will be to continue to foster growth and to expand the diversity of topics that have characterized the journal to date. My priority topic of focus will be the application of aerosol science to enhance human health with an emphasis on two areas:

1. Facilitating the development of novel inhaled therapeutics to meet the unmet needs of patients at all stages of the development pathway.
2. Increasing our understanding of the complex interactions between deposited particles and the airway microenvironment and the physiological processes that influence drug delivery.

Advancing these objectives will require cross-functional collaboration and sharing of insights. Any novel inhaled therapy that successfully advances from concept to commercialization will have needed to overcome a sequence of complex challenges any one of which has the capability of terminating the development process. Although the majority of approved inhaled drugs have been small molecules, the development pipeline will increasingly include more complex novel modalities such as gene-editing vectors or protein therapeutics, which may need to be delivered to airways that have undergone significant remodeling and have mucous hypersecretion. We hope the journal facilitates progress on these challenging topics and programs.

The editorial board has had meetings only at the biannual ISAM meeting and I will be reaching out to the board to gauge interest in virtual meetings that can increase the participation of the board members and to determine if there are topics in which the journal should take a more active interest, including the publication of special collections of articles with a common theme. Caroline Stamato, the managing editor, will facilitate these special collections.

The journal will continue to publish original and review articles. An additional category that we will be adding is called “Drug Development Perspectives.” These brief peer-reviewed opinion pieces by experts in drug development will focus on their vision of latest work in progress, their views on promising targets or retrospective lessons learned from prior efforts in drug development.

I look forward to working with this dynamic scientific community. I hope the journal continues to provide a forum that facilitates and inspires the development of innovative therapies that are needed by patients globally.

Link to the journal publication

The Journal of Aerosol Medicine and Pulmonary Drug Delivery

The Journal of Aerosol Medicine and Pulmonary Drug Delivery is the official Journal of the ISAM society. Our Journal is published by the leading publisher in the biomedical and biotechnology industries, Mary Ann Liebert, Inc., has an exceptional opportunity for an ambitious academic or industry scientist to play a pivotal role as Editor-in-Chief in driving the continued success of Journal of Aerosol Medicine and Pulmonary Drug Delivery, the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system.

The journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient. The audience includes respiratory specialists, pulmonary specialists, internal medicine specialists, pharmaceutical researchers, and equipment manufacturers, among others.

The EIC will will serve as as an ex officio member of the board of the International Society for Aerosols in Medicine as stated in our statutes.

The new EIC role will begin in late 2021 with a multi-year appointment.

Questions about the position and applications for the EIC position can be emailed to Jessica Downey, Journal Publishing Manager. Applicants are required to submit a CV and a statement of interest that includes their vision for the journal (details below).

Position Expectations - Editor-in-Chief (EIC)

The role of the EIC is to provide editorial oversight and strategy, to recruit and attract submissions to the journal, and to ensure the timeliness of publication of all journal content. One of the main priorities of the EIC is to solicit original research and review articles on key topics, and to be a fundamental advocate for the journal. The EIC will establish the working management of the journal, including appointing Associate Editors to manage manuscript submissions and editorial board members. Journal of Aerosol Medicine and Pulmonary Drug Delivery is a subscription journal that offers authors open access publishing options.

The EIC is responsible for communicating with authors and reviewers, as needed, regarding substantive manuscript content and review queries, and will ensure all standards for scientific publishing, including publication ethics, are adhered to, maintained, and implemented.

Requirements

• Highly organized, motivated individual with the skills and talent to continue to develop a highly regarded journal in an aggressive marketplace
• Broad research interests and a record of successful publication
• Editorial and peer review experience in biomedical or biotechnology journals Publishing experience as an author; reviewing and/or editorial board member experience highly desirable
• Experience with online manuscript submission systems is a plus; willingness to learn and use ScholarOne Manuscript Central system
• Strong network and reputation nationally and internationally
• Solid knowledge of industry activities and contacts in the field
• Advocacy for open access publishing and social media
• This is an independent-contractor position (with honorarium)

Application

Your application must include:

• Curriculum Vitae
• A letter of interest outlining your plans and aspirations for Journal of Aerosol Medicine and Pulmonary Drug Delivery (500 words)

The deadline for application submission is November 31. Please send the above materials via email to Jessica Downey, Journal Publishing Manager.

ISAM's detailed tobacco policy can be found here:

ISAM Tobacco Policy 

The signed ISAM statement:

ISAM Statement Vectura - PMI

Prof. Barbara Rothen-Rutishauser, ISAM President

It was time to turn some of our attention to the ISAM website. Over the past year, we were incredibly busy improving our virtual offers for members, congress and webinar participants. Our website team and the board have worked incredibly hard to create a modern, clean, and uncluttered website with improved functionality, clear navigation links, and a fantastic new member area that offers many different ways to interact. The new website reflects who ISAM is and provides a platform for ISAM to further develop.

Barbara Rothen-Rutishauser, Ph.D., President of ISAM

The new website is available under the know domain URL: https://isam.org

• Our new website provides easy access to data for non-members with following pages:
  
• homepage with links to subpages
  
• Events page with overview of all events and a list of upcoming events and our congresses subpages
  
• Publications that are offered free to our  members and can be purchased by non-members
  
• Link to the Journal of Aerosol Medicine (free for members)
  
• Our News page
  
• Awards granted by ISAM with presentation of this year awardees
• Exclusive Member area

All members and subscribers have received an email to sign-in and update their passwords. Please complete your profile and then join your:

• Networking Groups
• ISAM Community Blog
• Discussion Forum
• Connect to other ISAM members and benefit from receiving and sharing information
• Read and download content that is only intended for members (e.g. ISAM Handbook, Journal articles, Congress presentation)

Instructions for Members How to Enter the New ISAM Website

Step 1: Follow the link that you have received via email and update your password.

Step 2: Sign in with your new account details

Step 3: Update your account details (e.g. name, address, biography, security settings)

How to access the Journal of Aerosol Medicine and Pulmonary Drug Delivery

To access JAMPDD, follow the instructions below:

• Select "Member Area" from the main menu and login
• Click on "Quick Links"
• Select "Journal Access

ISAM thanks all members who helped to build up the Website and provide content that is now shared with our new website.

How to access ERS e-learning content

To access the ERS e-learning content, follow the instructions below:

• Select "Member Area" from the main menu and login 
• Click on "Quick Links" 
• Select "ERS e-learning"

You will be forwarded to the ERS e-learning page providing many online data available for download.

How to Renew Your Membership

1. Sign-in to the Membership Area

2. Select 'Renew Membership Now' from the 'Welcome' menu

3. Select your prefered Membership (e.g. Joint ISAM-ERS Membership - $280.00)

4. Complete required information and contact details, accept terms

5. Please ALWAYS select the 'PayPal' button to check out. You are then forwarded to PayPal, where you can pay with directly with PayPal OR by selection of CREDIT CARD for payment. Please use CONTACT US to contact us if you run into any issues.

Contact us if you require help

Please use our contact form or contact office@isam.org if you require help in accessing your member profile. Our ISAM office will help you to activate your account or direct you to find the right access point to your data.